Skip to content

    Research Use Only

    This site is an educational resource for research compounds. We do not endorse human consumption of any compound. BodyHackGuide and BHG Labs share common ownership; we rank every vendor on the same public methodology, and we earn a commission on purchases through our links. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.

    100K+ researchers trust BodyHackGuide — Join r/BodyHackGuide
    RecoveryPreclinical

    Glow Blend Dosage Guide: Protocols, Calculator & Safety

    Everything you need to know about Glow Blend dosing — protocols, safety, and where to buy.

    Dose Range

    Blend - stated per component: GHK-Cu 1000-2000 mcg/day; BPC-157 250-500 mcg/dose; TB-500 2000-2500 mcg/dose. No validated dose exists for the combination (Research Use Only).

    Frequency

    GHK-Cu once daily; BPC-157 once to twice daily; TB-500 twice weekly during the loading phase, then every 1-2 weeks for maintenance.

    Cycle Length

    Community cycles typically run 4-8 weeks followed by an off period of several weeks. No evidence supports continuous use.

    Half-Life

    Varies by component - the blend has no single half-life. BPC-157 and the TB-500 (thymosin beta-4) fragment are small peptides cleared over hours; GHK-Cu is a short-lived tripeptide-copper complex. Community dosing frequency is driven by empirical practice, not by measured pharmacokinetics of the blend.

    Dosage Calculator

    Calculate exact dosing for Glow Blend.

    Dosing Protocols

    Beginner

    Research Use Only - not medical advice. Doses below are stated per component (how much of each is present per injection); the blend itself has never been dosed in a study, so these are community-reported ranges. Beginners typically start at the low end of every component and run a single short cycle.

    • GHK-Cu: 1 mg subcutaneous, once daily
    • BPC-157: 250 mcg subcutaneous, once daily (often injected near the area of interest in anecdotal use)
    • TB-500: 2 mg subcutaneous, twice weekly (loading)

    Typical cycle: 4 weeks. Reconstitute with bacteriostatic water, refrigerate after mixing, and rotate injection sites. Start low, assess tolerance, and stop if any adverse reaction appears. See GHK-Cu, BPC-157 and TB-500 for per-component detail. If your only goal is skin appearance, a topical GHK-Cu cosmetic is the lower-risk starting point and avoids injections entirely.

    Standard

    Research Use Only - not medical advice. A standard community cycle after tolerating a beginner run, expressed per component:

    • GHK-Cu: 1.5-2 mg subcutaneous, once daily
    • BPC-157: 250-500 mcg subcutaneous, once or twice daily
    • TB-500: 2-2.5 mg subcutaneous, twice weekly for a 4-6 week loading phase

    Typical cycle: ~6 weeks, followed by a 4+ week off period. Many users inject BPC-157 near the recovering tissue and keep GHK-Cu systemic (or switch GHK-Cu to a topical cosmetic formulation for skin-only goals). No data support running this continuously. See BPC-157 and TB-500 for component-level notes.

    Advanced

    Research Use Only - not medical advice. Higher exposure carries higher unknown risk and is NOT better supported by evidence. Per component:

    • GHK-Cu: 2 mg subcutaneous, once daily
    • BPC-157: 500 mcg subcutaneous, twice daily
    • TB-500: 2-2.5 mg subcutaneous, twice weekly loading for 4-6 weeks, then a single 2-2.5 mg maintenance dose every 1-2 weeks

    Typical structure: 6-8 week loading, then taper to maintenance, then cycle off. Experienced users often keep the three components in separate vials for independent titration rather than a fixed premix, because the ideal ratio for the blend has never been studied. There is no established clinical ceiling for any of these peptides in humans - dosing above component community norms is not evidence-based. See GHK-Cu, BPC-157 and TB-500.

    Side Effects & Safety

    Most reported effects are local: injection-site redness, swelling, itching, bruising or transient pain, plus mild skin sensitivity. GHK-Cu injections can sting, and with prolonged high-dose systemic use there is a theoretical concern for copper accumulation. BPC-157 and TB-500 are generally described as well tolerated in animal studies and community use, but neither has undergone the long-term human safety testing that would define a real side-effect profile - unknown long-term risk is the honest bottom line. Rare: allergic/hypersensitivity reaction to any component. Because TB-500 and BPC-157 are angiogenic (they promote blood-vessel growth), there is a theoretical caution around active or undiagnosed cancer. Any report specific to this blend is anecdotal.

    Contraindications

    Do not use with a known allergy to any component (GHK-Cu, BPC-157 or TB-500) or to copper. Avoid injecting into active skin infections or broken/inflamed skin. Not for use in pregnancy or breastfeeding. Because two of the three components promote angiogenesis, avoid with active cancer or a personal history of cancer, or speak with a physician first. Use caution with Wilson's disease or other copper-metabolism disorders due to the copper in GHK-Cu. This is a Research Use Only product, not approved for human therapeutic use; anyone considering it should consult a qualified clinician.

    Check interactions with the Interaction Checker →

    Additional Notes

    Doses are expressed per component because Glow Blend has no studied ratio. Reconstitute with bacteriostatic water, refrigerate after mixing, and rotate subcutaneous injection sites. GHK-Cu can alternatively be used in a topical cosmetic formulation when the goal is skin appearance only. This is a Research Use Only product; the numbers here are extrapolated from each component's individual use and are not medical advice.

    Where to Buy Glow Blend

    Compare 3 listings across 3 vendors — from $29.99

    Frequently Asked Questions

    What is the recommended Glow Blend dosage?

    The typical dose range for Glow Blend is Blend - stated per component: GHK-Cu 1000-2000 mcg/day; BPC-157 250-500 mcg/dose; TB-500 2000-2500 mcg/dose. No validated dose exists for the combination (Research Use Only).. It is usually administered GHK-Cu once daily; BPC-157 once to twice daily; TB-500 twice weekly during the loading phase, then every 1-2 weeks for maintenance.. Always start with the lowest effective dose.

    How often should I take Glow Blend?

    GHK-Cu once daily; BPC-157 once to twice daily; TB-500 twice weekly during the loading phase, then every 1-2 weeks for maintenance.

    Does Glow Blend need to be cycled?

    Yes, typical cycle length is Community cycles typically run 4-8 weeks followed by an off period of several weeks. No evidence supports continuous use..

    What are Glow Blend side effects?

    Most reported effects are local: injection-site redness, swelling, itching, bruising or transient pain, plus mild skin sensitivity. GHK-Cu injections can sting, and with prolonged high-dose systemic use there is a theoretical concern for copper accumulation. BPC-157 and TB-500 are generally described as well tolerated in animal studies and community use, but neither has undergone the long-term human safety testing that would define a real side-effect profile - unknown long-term risk is the honest bottom line. Rare: allergic/hypersensitivity reaction to any component. Because TB-500 and BPC-157 are angiogenic (they promote blood-vessel growth), there is a theoretical caution around active or undiagnosed cancer. Any report specific to this blend is anecdotal.

    Where can I buy Glow Blend?

    Compare 3 listings from 3 vendors on our price comparison page — starting from $29.99.

    Free 2026 Peptide Cheat Sheet — 50 pages, PDF

    Reconstitution math, concentration charts, half-lives, and vendor trust tiers. The reference we wish we had on day one.

    Download Free
    Shop BHG Labs · 20% off with BHG20